Literature DB >> 26921166

Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data.

Stephen J Tueller1, Pascal R Deboeck2, Richard A Van Dorn3.   

Abstract

Medication adherence is thought to be the principal clinical predictor of positive clinical outcomes, not only for serious mental illnesses such as schizophrenia, bipolar disorder, or depression, but also for physical conditions such as diabetes. Consequently, research on medication often looks not only at medication condition (e.g., placebo, standard medication, investigative medication), but also at adherence in taking those medications within each medication condition. The percentage (or proportion) scale is one of the more frequently employed and easily interpretable measures. Patients can be 0 % adherent, 100 % adherent, or somewhere in between. For simplicity, many reported adherence analyses dichotomize or trichotomize the adherence predictor when estimating its effect on outcomes of interest. However, the methodological literature shows that the practice of categorizing continuously distributed predictors reduces statistical power at best and, at worst, can severely bias parameter estimates. This can result in inflated Type I errors (false positive acceptance of null adherence effects) or Type II errors (false negative rejection of true adherence effects). We extend the methodological literature on categorization to the construct of adherence. The measurement scale of adherence leads to a diverse family of potential distributions including uniform, n-shaped, u-shaped (i.e., bimodal), positively skewed, and negatively skewed. Using a simulation study, we generated negative, null, and positive "true" effects of adherence on simulated continuous and binary outcomes. We then estimated the adherence effect with and without categorizing the adherence variable. We show how parameter estimates and standard errors can be severely biased when categorizing adherence. The categorization of adherence is shown to cause null effects to become positive or negative depending on the distribution of the simulated adherence variable, inflating Type I errors. When the adherence effect was significantly different from zero, categorization can render the effect null, inflating Type II errors. We recommend that adherence be measured continuously and analyzed without categorization when using it as a predictor in regression models.

Entities:  

Keywords:  Adherence; General medicine; Health behavior; Measurement; Serious mental illness

Mesh:

Year:  2016        PMID: 26921166      PMCID: PMC5002256          DOI: 10.1007/s10865-016-9727-9

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  53 in total

Review 1.  A meta-analysis of the association between adherence to drug therapy and mortality.

Authors:  Scot H Simpson; Dean T Eurich; Sumit R Majumdar; Rajdeep S Padwal; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2006-06-21

2.  Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.

Authors:  Paul A Nakonezny; Matthew J Byerly; A John Rush
Journal:  Psychiatry Res       Date:  2007-11-01       Impact factor: 3.222

3.  Should full adherence be a necessary goal in schizophrenia? Full versus non-full adherence to antipsychotic treatment.

Authors:  Francisco J Acosta; Yolanda Ramallo-Fariña; Samuel G Siris
Journal:  Compr Psychiatry       Date:  2013-10-08       Impact factor: 3.735

4.  Impact of medication adherence on hospitalization risk and healthcare cost.

Authors:  Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

5.  Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients.

Authors:  Franco Maggiolo; Monica Airoldi; Hendrik Daniël Kleinloog; Annapaola Callegaro; Veronica Ravasio; Claudio Arici; Enrico Bombana; Fredy Suter
Journal:  HIV Clin Trials       Date:  2007 Sep-Oct

6.  Non-adherence to antipsychotic medication regimens: associations with resource use and costs.

Authors:  Martin Knapp; Derek King; Klaus Pugner; Pablo Lapuerta
Journal:  Br J Psychiatry       Date:  2004-06       Impact factor: 9.319

7.  Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.

Authors:  Marcia Valenstein; Laurel A Copeland; Frederic C Blow; John F McCarthy; John E Zeber; Leah Gillon; C Raymond Bingham; Thomas Stavenger
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

Review 8.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

9.  Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study.

Authors:  Erin K Buysman; Fang Liu; Mette Hammer; Jakob Langer
Journal:  Adv Ther       Date:  2015-04-02       Impact factor: 3.845

10.  The cost of relapse and the predictors of relapse in the treatment of schizophrenia.

Authors:  Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; David Salkever; Eric P Slade; Xiaomei Peng; Robert R Conley
Journal:  BMC Psychiatry       Date:  2010-01-07       Impact factor: 3.630

View more
  6 in total

1.  Treatment adherence and illness self-management: introduction to the special issue.

Authors:  M Bryant Howren; Jeffrey S Gonzalez
Journal:  J Behav Med       Date:  2016-10-20

2.  Patterns of transitions between relapse to and remission from heavy drinking over the first year after outpatient alcohol treatment and their relation to long-term outcomes.

Authors:  Stephen A Maisto; Kevin A Hallgren; Corey R Roos; Julia E Swan; Katie Witkiewitz
Journal:  J Consult Clin Psychol       Date:  2020-12

3.  Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy.

Authors:  Samuel W Terman; Wesley T Kerr; Zachary A Marcum; Lu Wang; James F Burke
Journal:  Epilepsia       Date:  2021-08-31       Impact factor: 5.864

Review 4.  Patients' adherence to smartphone apps in the management of bipolar disorder: a systematic review.

Authors:  Marie-Camille Patoz; Diego Hidalgo-Mazzei; Bruno Pereira; Olivier Blanc; Ingrid de Chazeron; Andrea Murru; Norma Verdolini; Isabella Pacchiarotti; Eduard Vieta; Pierre-Michel Llorca; Ludovic Samalin
Journal:  Int J Bipolar Disord       Date:  2021-06-03

5.  Social Support Moderates Effects of Natural Disaster Exposure on Depression and Posttraumatic Stress Disorder Symptoms: Effects for Displaced and Nondisplaced Residents.

Authors:  Adam P McGuire; Jami M Gauthier; Lisa M Anderson; David W Hollingsworth; Melissa Tracy; Sandro Galea; Scott F Coffey
Journal:  J Trauma Stress       Date:  2018-04-05

6.  Housing First Improves Adherence to Antipsychotic Medication Among Formerly Homeless Adults With Schizophrenia: Results of a Randomized Controlled Trial.

Authors:  Stefanie N Rezansoff; Akm Moniruzzaman; Seena Fazel; Lawrence McCandless; Ric Procyshyn; Julian M Somers
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.